Triple Negative Breast Cancers
Although triple negative breast cancers have been around forever, the term is relatively new. Women who are diagnosed with this particular kind of breast cancer are often even more anxious because they know that their cancers are not responsive to treatment with herceptin (for her2 positive cancers) or hormonal therapies (for ER positive cancers). However, triple negative breast cancers are especially sensitive to chemotherapy, so the reassurance is that those drugs will be particularly helpful.
Here is a summary and then a link to LBBC's (www.lbbc.org) recent teleconference about triple negative cancers. You can read the transcript or listen to it.
Living Beyond Breast Cancer in partnership with the Triple Negative Breast Cancer Foundation hosted our April teleconference on Triple-Negative Breast Cancer: Treatment Update and Tools for Healthy Living.
Lyndsay N. Harris, MD, of the Yale School of Medicine and Yale Cancer Center Breast Cancer Program, and Suzanne Dixon, MPH, MS, RD, of The Health Geek, LLC, provided an overview of triple-negative breast cancers, including:
- The latest research and treatments
- Risk factors and screening
- Nutritional and lifestyle tools to reduce your risk of recurrence
What Is Triple-Negative Breast Cancer?
Triple-negative breast cancers are cancers that test negative for the estrogen and progesterone receptor and HER2 protein.